Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients
Ottawa Hospital Research Institute
Ottawa Hospital Research Institute
Xperiome
Rutgers, The State University of New Jersey
X4 Pharmaceuticals
Memorial Sloan Kettering Cancer Center